[Feminizing adrenal tumours in Spain: report of a case and review of the five previously published patients].
Feminizing adrenal tumours are very rare. We report the clinical and hormonal study of a case, a 49 years old male, since his first consultation until his death 6 years after the initial diagnosis, and a review of the other 5 Spanish patients previously published. His initial symptoms were gynecomastia and libido decrease, with increase of plasmatic and urinary oestrogen levels, plasma testosterone near low normal level and a right adrenal gland tumour that, after its removal, showed a benign histology and was classified as an adrenocortical adenoma. Three years after, initial symptoms returned, with oestrogen, glucocorticoid and androgen hypersecretion, tumour local relapse and peritoneal, liver and lung metastasis. After mitotane and aminoglutethimide therapy, hormonal concentrations fell temporary and then raised again until his death 3 years later. The main special feature of this case is the apparently benign initial adrenal tumour with only oestrogen hypersecretion, and its relapse 3 years later with secretion of several steroid hormones, generalized metastasis and no response to medical therapy.
Andía Melero
Víctor Manuel
VM
Servicio de Endocrinología. Hospital General Universitario Gregorio Marañón. Madrid. España.
García Centeno
Rogelio
R
Fernández
Jesús Bayort
JB
Vigovich
Carlos
C
Sánchez García-Cervigón
Petra
P
Jara Albarrán
Antonino
A
D000236:Adenoma / Q000150:complications* / Q000473:pathology; D000310:Adrenal Gland Neoplasms / Q000150:complications* / Q000473:pathology; D005262:Feminization / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000150:complications; D013030:Spain